Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Immunity Pharma Announces Promising Interim Results of Study with IPL344 in ALS

americanpharmaceuticalreviewSeptember 22, 2020

Tag: IPL344 , ALS , Immunity Pharma

PharmaSources Customer Service